This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials

Thursday, March 24, 2022

Submitted by


Michael O'Riordan

Several surgical associations have given a new statement in response to the new Valve Academic Research Consortium (VARC) definitions for aortic valve clinical studies. They took issue with a few things, most notably, rehospitalization, bleeding, and myocardial infarction.

Add comment

Log in or register to post comments